Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1857 1
1921 1
1965 1
1966 1
1967 1
1969 2
1970 1
1972 2
1974 2
1976 3
1977 2
1978 4
1979 6
1980 1
1981 3
1982 5
1983 4
1984 7
1985 5
1986 6
1987 1
1988 2
1989 7
1990 4
1991 8
1992 5
1993 8
1994 5
1995 7
1996 6
1997 11
1998 8
1999 7
2000 6
2001 6
2002 12
2003 7
2004 1
2005 6
2006 4
2007 11
2008 16
2009 13
2010 9
2011 13
2012 12
2013 18
2014 19
2015 24
2016 19
2017 25
2018 24
2019 37
2020 32
2021 44
2022 40
2023 32
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

538 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for wenham an
Search for Wenhan An instead (3 results)
In Reply.
Chan JK, Tian C, Kesterson JP, Monk BJ, Kapp DS, Davidson B, Robertson S, Copeland LJ, Walker JL, Wenham R, Casablanca Y, Spirtos NM, Tewari KS, Bell JG. Chan JK, et al. Obstet Gynecol. 2022 Jun 1;139(6):1196-1197. doi: 10.1097/AOG.0000000000004817. Obstet Gynecol. 2022. PMID: 35675622 No abstract available.
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer.
Moore KN, Angelergues A, Konecny GE, García Y, Banerjee S, Lorusso D, Lee JY, Moroney JW, Colombo N, Roszak A, Tromp J, Myers T, Lee JW, Beiner M, Cosgrove CM, Cibula D, Martin LP, Sabatier R, Buscema J, Estévez-García P, Coffman L, Nicum S, Duska LR, Pignata S, Gálvez F, Wang Y, Method M, Berkenblit A, Bello Roufai D, Van Gorp T; Gynecologic Oncology Group Partners and the European Network of Gynaecological Oncological Trial Groups. Moore KN, et al. N Engl J Med. 2023 Dec 7;389(23):2162-2174. doi: 10.1056/NEJMoa2309169. N Engl J Med. 2023. PMID: 38055253 Clinical Trial.
Author reply.
Wenham J, Best M, Kissane DW AC. Wenham J, et al. Intern Med J. 2022 Jan;52(1):164. doi: 10.1111/imj.15646. Intern Med J. 2022. PMID: 35060286 No abstract available.
Heparin-induced thrombocytopaenia.
Prince M, Wenham T. Prince M, et al. Postgrad Med J. 2018 Aug;94(1114):453-457. doi: 10.1136/postgradmedj-2018-135702. Epub 2018 Aug 20. Postgrad Med J. 2018. PMID: 30126928 Review.
Preparing for the next pandemic.
Wenham C, Kavanagh M, Torres I, Yamey G. Wenham C, et al. BMJ. 2021 May 21;373:n1295. doi: 10.1136/bmj.n1295. BMJ. 2021. PMID: 34020969 No abstract available.
IgA transcytosis and antigen recognition govern ovarian cancer immunity.
Biswas S, Mandal G, Payne KK, Anadon CM, Gatenbee CD, Chaurio RA, Costich TL, Moran C, Harro CM, Rigolizzo KE, Mine JA, Trillo-Tinoco J, Sasamoto N, Terry KL, Marchion D, Buras A, Wenham RM, Yu X, Townsend MK, Tworoger SS, Rodriguez PC, Anderson AR, Conejo-Garcia JR. Biswas S, et al. Nature. 2021 Mar;591(7850):464-470. doi: 10.1038/s41586-020-03144-0. Epub 2021 Feb 3. Nature. 2021. PMID: 33536615 Free PMC article.
UK's evolving role in global health.
Khan MS, Wenham C, Dar OA. Khan MS, et al. BMJ. 2024 Feb 20;384:q426. doi: 10.1136/bmj.q426. BMJ. 2024. PMID: 38378196 No abstract available.
Carboplatin dosing in the treatment of ovarian cancer: An NRG oncology group study.
Praiss AM, Miller A, Smith J, Lichtman SM, Bookman M, Aghajanian C, Sabbatini P, Backes F, Cohn DE, Argenta P, Friedlander M, Goodheart MJ, Mutch DG, Gershenson DM, Tewari KS, Wenham RM, Wahner Hendrickson AE, Lee RB, Gray H, Secord AA, Van Le L, O'Cearbhaill RE. Praiss AM, et al. Gynecol Oncol. 2023 Jul;174:213-223. doi: 10.1016/j.ygyno.2023.05.013. Epub 2023 May 23. Gynecol Oncol. 2023. PMID: 37229879 Clinical Trial.
Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial.
Del Campo JM, Matulonis UA, Malander S, Provencher D, Mahner S, Follana P, Waters J, Berek JS, Woie K, Oza AM, Canzler U, Gil-Martin M, Lesoin A, Monk BJ, Lund B, Gilbert L, Wenham RM, Benigno B, Arora S, Hazard SJ, Mirza MR. Del Campo JM, et al. J Clin Oncol. 2019 Nov 10;37(32):2968-2973. doi: 10.1200/JCO.18.02238. Epub 2019 Jun 7. J Clin Oncol. 2019. PMID: 31173551 Free PMC article. Clinical Trial.
538 results